Biostatistics in clinical trials /
Saved in:
| Imprint: | Chichester [England] ; New York : J. Wiley, c2001. |
|---|---|
| Description: | xx, 501 p. : ill. ; 26 cm. |
| Language: | English |
| Series: | The Wiley reference series in biostatistics Wiley reference series in biostatistics. |
| Subject: | |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/4424163 |
MARC
| LEADER | 00000pam a22000004a 4500 | ||
|---|---|---|---|
| 001 | 4424163 | ||
| 003 | ICU | ||
| 005 | 20031020162400.0 | ||
| 008 | 010208s2001 enka b 001 0 eng | ||
| 010 | |a 2001017865 | ||
| 020 | |a 0471822116 (alk. paper) | ||
| 035 | |a 2001017865 | ||
| 040 | |a DLC |c DLC |d NhCcYBP |d OCoLC |d OrLoB-B | ||
| 042 | |a pcc | ||
| 050 | 0 | 0 | |a R853.S7 |b B49 2001 |
| 082 | 0 | 0 | |a 619 |2 21 |
| 245 | 0 | 0 | |a Biostatistics in clinical trials / |c editors, Carol K. Redmond, Theodore Colton. |
| 260 | |a Chichester [England] ; |a New York : |b J. Wiley, |c c2001. | ||
| 300 | |a xx, 501 p. : |b ill. ; |c 26 cm. | ||
| 336 | |a text |b txt |2 rdacontent |0 http://id.loc.gov/vocabulary/contentTypes/txt | ||
| 337 | |a unmediated |b n |2 rdamedia |0 http://id.loc.gov/vocabulary/mediaTypes/n | ||
| 338 | |a volume |b nc |2 rdacarrier |0 http://id.loc.gov/vocabulary/carriers/nc | ||
| 490 | 1 | |a The Wiley reference series in biostatistics | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | 0 | |t Adaptive and Dynamic Methods of Treatment Assignment -- |t Antibacterial Agent Trials -- |t Audit and Quality Control -- |t Bayesian Methods -- |t Benefit/Risk Assessment -- |t Blinding or Masking -- |t Clinical Significance Versus Statistical Significance -- |t Clinical Trials, Overview -- |t Cluster Randomization -- |t Cochrane Collaboration -- |t Community Intervention Trials -- |t Compliance Assessment -- |t Consort -- |t Controlled Clinical Trials -- |t Cooperative Cancer Trials -- |t Cooperative Heart Disease Trials -- |t Cooperative Studies Program, US Department of Veterans Affairs -- |t Cost-effectiveness -- |t Covariate Imbalance, Adjustment for -- |t Crossover Designs -- |t Data and Safety Monitoring -- |t Data and Safety Monitoring Boards -- |t Data Management and Coordination -- |t Drug Approval and Regulation -- |t Drug Interaction -- |t Eligibility and Exclusion Criteria -- |t Equivalence Trials -- |t Ethics -- |t European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) -- |t European Organization for Research and Treatment of Cancer (EORTC) -- |t Factorial Designs -- |t Fraud -- |t Group-randomization Designs -- |t Guidelines -- |t Historical Controls, Bias From -- |t History, Early Cancer and Heart Disease Trials -- |t History, Overview -- |t Intention-to-Treat Analysis -- |t International Studies of Infarct Survival (ISIS) -- |t Medical Ethics and Statistics -- |t Medical Research Council (MRC) Streptomycin Trial -- |t Meta-analysis -- |t Missing Data -- |t Multicenter Trials -- |t Multiple Endpoints -- |t Multiplicity -- |t Noncompliance, Adjustment for -- |t Nonrandomized Trials -- |t NSABP and Advances in the Treatment of Breast Cancer -- |t Number Needed to Treat (NNT) -- |t Outcome Measures -- |t Pharmaceutical Industry, Statistics in -- |t Phase I Trials -- |t Phase II Trials -- |t Physicians' Health Study -- |t Postmarketing Surveillance of New Drugs and Assessment of Risk -- |t Preclinical Treatment Evaluation -- |t Prevention Trials -- |t Protocols -- |t QUOROM -- |t Randomization -- |t Randomized Treatment Assignment -- |t Salk Vaccine -- |t Sample Size Determination -- |t Screening Trials -- |t Sequential Methods -- |t Society for Clinical Trials -- |t Software -- |t Statistical Review for Medical Journals -- |t Statistical Review for Medical Journals, Guidelines for Authors -- |t Statisticians in the Pharmaceutical Industry (SPI) -- |t Surrogate Endpoints -- |t Textbooks -- |t Time-varying Treatment Effect -- |t Treatment-Covariate Interaction -- |t University Group Diabetes Program (UGDP) -- |t Vaccine Studies. |
| 650 | 0 | |a Clinical trials |x Statistical methods. |0 http://id.loc.gov/authorities/subjects/sh2009120433 | |
| 650 | 7 | |a Clinical trials |x Statistical methods. |2 fast |0 http://id.worldcat.org/fast/fst00864440 | |
| 700 | 1 | |a Redmond, Carol K. |0 http://id.loc.gov/authorities/names/n81118745 |1 http://viaf.org/viaf/37139107 | |
| 700 | 1 | |a Colton, Theodore. |0 http://id.loc.gov/authorities/names/n88220392 |1 http://viaf.org/viaf/66636458 | |
| 830 | 0 | |a Wiley reference series in biostatistics. |0 http://id.loc.gov/authorities/names/n00012437 | |
| 901 | |a ToCBNA | ||
| 903 | |a HeVa | ||
| 903 | |a Hathi | ||
| 035 | |a (OCoLC)45917064 | ||
| 929 | |a cat | ||
| 999 | f | f | |i 11f5f6f4-a386-568d-887b-5a280873f144 |s ecdef42b-2d0e-53d9-9864-02cd069f9ad5 |
| 928 | |t Library of Congress classification |a R853.S7 B49 2001 |l JCL |c JCL-Sci |i 4505773 | ||
| 927 | |t Library of Congress classification |a R853.S7 B49 2001 |l JCL |c JCL-Sci |e CRERAR |b 57545098 |i 7015616 | ||
